Table 2.
The correlation of protein level of HSPD1 and survival by different clinicopathological outcomes in BMSCC patients.
| Variable | No. (%) | AHR (95% CI) | p value | |
|---|---|---|---|---|
| Disease-specific survival | ||||
| T classification | T1, T2 | 141 (75.8) | 1.00 | |
| T3, T4 | 45 (24.2) | 1.42 (0.86–2.32) | 0.168 | |
| N classification | N0 | 138 (74.2) | 1.00 | |
| N1, N2 | 48 (25.8) | 3.85 (2.28–6.50) | <0.001 | |
| Cell differentiation | Well | 50 (26.9) | 1.00 | |
| Moderate, poor | 136 (73.1) | 1.51 (0.80–2.87) | 0.205 | |
| Disease-free survival | ||||
| T classification | T1, T2 | 141 (75.8) | 1.00 | |
| T3, T4 | 45 (24.2) | 0.79 (0.46–1.34) | 0.379 | |
| N classification | N0 | 138 (74.2) | 1.00 | |
| N1, N2 | 48 (25.8) | 2.00 (1.22–3.29) | 0.006 | |
| Cell differentiation | Well | 50 (26.9) | 1.00 | |
| Moderate, poor | 136 (73.1) | 1.60 (0.90–2.86) | 0.110 | |
Abbreviations: AHR, adjusted hazard ratio; BMSCC, buccal mucosa squamous cell carcinoma; CI, confidence interval.
p values were estimated by multivariate Cox’s regression.
p values were adjusted for cell differentiation (moderate + poor vs. well), T classification(T3 + T4 vs T1 + T2), and N classification(N1 + N2 vs N0).